Form 4 Filing for CG Oncology, Inc. - Officer/Director Transaction

This filing reports a Form 4 for CG Oncology, Inc. (CGON), detailing a stock option grant to Christina Rossi, identified as a director. The transaction, dated June 4, 2026, involved the acquisition of 9,354 Director Stock Options with a right to buy Common Stock. The options have an exercise price of $56.09 and an expiration date of June 3, 2036. The option vests 1/12th monthly starting from June 4, 2026, contingent on continuous service. The reporting owner acquired these options and will hold 9,354 shares post-transaction. The filing was signed by Joshua Patterson as Attorney-in-Fact for Christina Rossi on June 5, 2026.